Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Window Trial 5-aza in HNSCC, T-tare

Phase 1

Completed

Conditions: Head and Neck Squamous Cell Carcinoma

Interventions: Drug: 5-Azacitadine

First Posted Date: 2014-06-30

Last Posted Date: 2022-02-15

Lead Sponsor: Yale University

Target Recruit Count: 18

Registration Number: NCT02178072

Locations: 🇺🇸
Smilow Cancer Center at Yale New Haven Hospital, New Haven, Connecticut, United States

Computerized Cognitive Behavioral Therapy and Electroconvulsive Therapy

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Computerized Cognitive Behavioral Therapy

First Posted Date: 2014-06-27

Last Posted Date: 2017-01-09

Lead Sponsor: Yale University

Target Recruit Count: 30

Registration Number: NCT02176473

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

The Effect of Cognitive Enhancement as a Precursor to Computer Based Training for Cognitive Behavioral Therapy (CBT4CBT)

Phase 1

Completed

Conditions: Cocaine Use Disorder

Interventions: Behavioral: Treatment As Usual (TAU)
Behavioral: TAU plus Rapid Abstinence Initiation (RAI)
Behavioral: TAU plus RAI plus Cognitive Control Training (CCT)

First Posted Date: 2014-06-25

Last Posted Date: 2020-10-14

Lead Sponsor: Yale University

Target Recruit Count: 99

Registration Number: NCT02174614

Locations: 🇺🇸
MCCA, New Haven, Connecticut, United States

SHOCK US STUDY: Fluid Responsiveness in Sepsis Measured by Ultrasonography

Completed

Conditions: Sepsis

First Posted Date: 2014-06-23

Last Posted Date: 2020-01-13

Lead Sponsor: Yale University

Target Recruit Count: 65

Registration Number: NCT02170233

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection

Phase 1

Completed

Conditions: Acute HIV Infection
HIV Infections

Interventions: Drug: Telmisartan

First Posted Date: 2014-06-23

Last Posted Date: 2020-03-09

Lead Sponsor: Yale University

Target Recruit Count: 21

Registration Number: NCT02170246

Locations: 🇹🇭
Chulalongkorn University Hospital, Bangkok, Thailand
🇹🇭
Thai Red Cross AIDS Research Centre, Bangkok, Thailand

Development of a Nationally Scalable Model of Group Prenatal Care to Improve Birth Outcomes: "Expect With Me"

Not Applicable

Completed

Conditions: Infant, Low Birth Weight
Sexually Transmitted Diseases
Postpartum Period
Pregnancy
Premature Birth

Interventions: Other: Standard individual prenatal care
Behavioral: Expect With Me group prenatal care

First Posted Date: 2014-06-20

Last Posted Date: 2020-05-29

Lead Sponsor: Yale University

Target Recruit Count: 2402

Registration Number: NCT02169024

Locations: 🇺🇸
Wayne State University, Detroit, Michigan, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease

Phase 2

Completed

Conditions: Alzheimer's Disease

Interventions: Drug: Placebo
Drug: AZD0530 100mg daily
Drug: AZD0530 125mg daily

First Posted Date: 2014-06-19

Last Posted Date: 2019-08-14

Lead Sponsor: Yale University

Target Recruit Count: 159

Registration Number: NCT02167256

Locations: 🇺🇸
Wien Center for Clinical Research/Mount Sinai Medical Center, Miami Beach, Florida, United States
🇺🇸
University of South Florida - Health Byrd Alzheimer Institute, Tampa, Florida, United States
🇺🇸
Rush University Medical Center, Chicago, Illinois, United States

and more 19 locations

A Reinforcement Approach to Improve Diabetes Management

Not Applicable

Completed

Conditions: Type 1 Diabetes

Interventions: Behavioral: Reinforcement for BG testing
Other: Standard of care

First Posted Date: 2014-06-19

Last Posted Date: 2021-01-19

Lead Sponsor: Yale University

Target Recruit Count: 62

Registration Number: NCT02167243

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma

Phase 1

Withdrawn

Conditions: Scleroderma
Systemic Sclerosis

Interventions: Drug: Divalproex sodium

First Posted Date: 2014-06-18

Last Posted Date: 2016-08-11

Lead Sponsor: Yale University

Registration Number: NCT02166229

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Does Guanfacine Attenuate Stress-Induced Drinking?

Phase 2

Completed

Conditions: Alcohol Drinking

Interventions: Drug: Guanfacine 1.5mg/day
Drug: Guanfacine 3mg/day
Drug: Placebo

First Posted Date: 2014-06-16

Last Posted Date: 2021-07-08

Lead Sponsor: Yale University

Target Recruit Count: 70

Registration Number: NCT02164422

Locations: 🇺🇸
Yale Center for Clinical Investigations, Yale University, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy